SLXP up +4.56% percent right now. $SLXP High is at 99.90

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:28 PM

SLXP up +4.56% percent right now. $SLXP High is at 99.90 and the Low 94.03 with current volume of 2,516,434.

Recent News posted below.

SLXP Salix Pharmaceuticals Recent Headline News

Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd.
PR Newswire - 18 mins ago
Barrett Business Services, Inc.
RYN: 26.50 (-2.32), BIO: 113.04 (+1.99), BBSI: 24.13 (-0.15), SLXP: 97.50 (+3.63), PME: 1.23 (+0.04)

Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - 2 hrs 46 mins ago
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 24.01 (-0.11), AGN: 195.69 (+0.45), ACT: 243.55 (-2.18), VRX: 128.23 (+0.24), MDT: 69.04 (+0.33), SLXP: 97.50 (+3.63), SNY: 46.76 (+0.57)

Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk
PR Newswire - Tue Nov 11, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), AstraZeneca PLC (NYSE: AZN), Novartis AG (NYSE: NVS), Impax Laboratories Inc. (NASDAQ: IPXL), and Novo Nordisk A/S (NYSE: NVO). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 10, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,613.74, up 0.23% and the NASDAQ Composite closed at 4,651.62, up 0.41%. The S&P 500 finished the session 0.31% higher at 2,038.26. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.00, up 1.00%, with the index gaining 11.86% in the previous three months. Register for your complimentary reports on these five stocks at:
IPXL: 29.26 (+0.21), NVO: 44.08 (+0.78), AZN: 74.14 (+0.93), SLXP: 97.50 (+3.63), NVS: 92.46 (-0.17)

Hagens Berman Alerts Investors of Lead Plaintiff Deadline in Class Action Lawsuit Filed Against Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP)
GlobeNewswire - Tue Nov 11, 7:38AM CST
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) ("Salix" or "the Company). The suit is pending in U.S. District Court for the Southern District of New York, and investors have until January 6, 2015 to move for lead plaintiff.
SLXP: 97.50 (+3.63)

Salix Pharmaceuticals: What Scares Me Most About Its High Inventory & Stock Collapse
Brian Nichols - at Seeking Alpha - Tue Nov 11, 6:50AM CST

SLXP: 97.50 (+3.63)

SALIX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Salix Pharmaceuticals Ltd. - SLXP
GlobeNewswire - Mon Nov 10, 9:00PM CST
Kahn Swick & Foti, LLC ("KSF"

and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 6, 2015 to file lead plaintiff applications in a securities class action lawsuit against Salix Pharmaceuticals Ltd. (Nasdaq:SLXP) if they purchased the Company's securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period"

. This action is pending in the United States District Court for the Southern District of New York.
SLXP: 97.50 (+3.63)

Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals, Ltd.
Business Wire - Mon Nov 10, 3:28PM CST
Rigrodsky & Long, P.A.:
SLXP: 97.50 (+3.63)

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Salix Pharmaceuticals, Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 6, 2015 -- SLXP
GlobeNewswire - Mon Nov 10, 3:11PM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Salix Pharmaceuticals, Ltd. ("Salix" or the "Company"

(Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014.
SLXP: 97.50 (+3.63)

Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Mon Nov 10, 1:56PM CST
Salix's (SLXP) wholesale inventory levels for its products were much higher than previously announced.
AGN: 195.69 (+0.45), VRX: 128.23 (+0.24), AUXL: 32.59 (-0.11), SLXP: 97.50 (+3.63)

Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
PR Newswire - Mon Nov 10, 11:09AM CST
Wolf Popper LLP is investigating potential claims on behalf of investors in Salix Pharmaceuticals Ltd. ("Salix"

common stock (NASDAQ: SLXP) during the period May 10, 2013 through November 6, 2014, concerning possible violations of federal securities laws. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 or fqian@wolfpopper.com.
SLXP: 97.50 (+3.63)

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP
GlobeNewswire - Mon Nov 10, 10:40AM CST
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Salix Pharmaceuticals Ltd. ("Salix" or the "Company"

(Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period"

.
SLXP: 97.50 (+3.63)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 173.48 (+1.33), SLXP: 97.50 (+3.63), ICPT: 174.94 (-1.41), IBB: 296.85 (+1.65), AGIO: 84.06 (+2.28)

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Nov 10, 8:51AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
SLXP: 97.50 (+3.63)

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:35AM CST
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
SLXP: 97.50 (+3.63)

Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
GlobeNewswire - Mon Nov 10, 8:30AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over alleged Federal Securities Laws Violations by Salix Pharmaceuticals, Ltd.
SLXP: 97.50 (+3.63)

Downgrade Alert for Salix Pharmaceuticals (SLXP)
Comtex SmarTrend(R) - Mon Nov 10, 8:04AM CST
Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $91.47 on volume of 25.8 million shares, above average daily volume of 2.0 million. In the past 52 weeks, shares of Salix Pharmaceuticals have traded between a low of $82.52 and a high of $172.98 and closed yesterday at $91.47, which is 11% above that low price. The 200-day and 50-day moving averages have moved 0.63% higher and 1.83% lower over the past week, respectively.
SLXP: 97.50 (+3.63)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.66 (+0.27), YHOO: 48.39 (-1.02), MNST: 107.44 (-0.32), ANF: 28.78 (+0.09), SLXP: 97.50 (+3.63), FFIV: 126.14 (-0.45), AKS: 6.32 (-0.31), TWTR: 38.86 (-0.73), GDX: 18.19 (+0.74), FXF: 101.08 (+0.24)

Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow"

filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period"

, purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company"

(Nasdaq:SLXP).
SLXP: 97.50 (+3.63)

SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"

, announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 97.50 (+3.63)

Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company"

(NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 97.50 (+3.63)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Joins Shanghai-HK Connect, Expanding Reach

Big News from Baidu: Connect Program Inclusion Bet you didn't see this one coming. Baidu, the titan of AI in China, just rolled out some significant buzz. Starting September 7th, their Class A ordinary shares will join the Shanghai-Hong Kong Stock Connect program, shaking things up on the Shanghai Stock Exchange. This move is set to give investors from the Chinese...

HoneyNaps Unveils Wireless PSG: Sleep Testing Revolution

Tearing Down the Wired Wall in Sleep Studies Well, here's a switch-up that's long overdue in the world of sleep disorders diagnostics. It looks like HoneyNaps has figured out how to ditch the tangled mess that is traditional polysomnography (PSG) with their new creation—a wireless PSG system, and I gotta say, I'm liking the sound of that. If you've ever been strapped to...

Terrabis Revolutionizes Illinois with Dual-Window Dispensary

Terrabis Unveils a Speedier Cannabis Experience What do you do when the world is demanding faster service? You innovate. That’s precisely what Terrabis has done by unveiling Illinois' first dual-window drive-thru dispensary in Grayville. Situated just off I-64, this facility isn't just offering a new way of doing things; it's setting the stage for what might very well...

Beko's Innovations in Appliances: Practical Gains Measured

Finding Efficiency in Everyday Routines Let’s kick things off with a no-nonsense look at Beko's thrust into the heart of day-to-day living. This isn’t about bells and whistles, folks—it's about delivering real, quantifiable improvements in how appliances serve us at home. Istanbul's latest reveal is a nod to practicality. From the onset, Beko wraps its hands around...

Baseus Debuts Innovations at IFA 2026: Earbuds to Security

Baseus Pumps New Blood into Tech Gadgets Well, if you're looking for some fresh tech pumping in from Berlin, Baseus tossed out some intriguing gizmos at IFA 2026 that'll perk up your ears. We're looking at an evolution from a brand that's clawed its way from everyday accessories to a full-blown tech ecosystem—pretty ambitious, if you ask me. Baseus isn't playing small...

Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

Western Computer Reaps Microsoft AI Honor: Impact & Insights

Western Computer Racks Up Another Microsoft Gong Alright, put down your coffee and listen up. When a company like Western Computer snags recognition from Microsoft a third time, they're not just ringing their own bell—they're practically sounding a bugle. Microsoft threw them into their AI Business Solutions Inner Circle for 2026/2027. That’s the gold club membership...

S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Hartford Students Get Boost from Hygiene Initiatives

Beyond Backpacks: Essential Hygiene for Hartford Kids When September rolls around, it’s not just about those shiny new backpacks and unopened notebooks. In good ol’ Hartford, some students find themselves in need of basics that get overlooked—a stick of deodorant, a bar of soap, maybe some period products. Skimp on these, and all of a sudden, showing up for school...

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...